학술논문
Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies
Document Type
article
Author
Florent Malard; Béatrice Gaugler; Joel Gozlan; Lucie Bouquet; Djeneba Fofana; Lama Siblany; Deborah Eshagh; Olivier Adotevi; Caroline Laheurte; Laure Ricard; Rémy Dulery; Nicolas Stocker; Zoe van de Wyngaert; Alexis Genthon; Anne Banet; Mara Memoli; Souhila Ikhlef; Simona Sestilli; Anne Vekhof; Eolia Brissot; Zora Marjanovic; Yannick Chantran; Nancy Cuervo; Eric Ballot; Laurence Morand-Joubert; Mohamad Mohty
Source
Blood Cancer Journal, Vol 11, Iss 8, Pp 1-8 (2021)
Subject
Language
English
ISSN
2044-5385
Abstract
Abstract This study evaluated the safety and immunogenicity of BNT162b2 vaccine in patients with hematological malignancies. Antibodies blocking spike binding to immobilized ACE-2 (NAb) correlated with anti-Spike (S) IgG d42 titers (Spearman r = 0.865, p